Company news

Oncosec Medical Incorporated (OTC:ONCSQ) news

Oncosec Medical Incorporated news releases on 6ix. Latest, May 27, 2015: OncoSec Medical Announces Uplisting to The NASDAQ Stock Market LLC

View Oncosec Medical Incorporated →

Press releases & updates

OncoSec Medical Announces Uplisting to The NASDAQ Stock Market LLC

May 27, 2015

OncoSec Medical to Present Data at the New York Academy of Sciences' Cancer Immunotherapy Symposium

May 20, 2015

OncoSec Medical Announces FINRA Approval of Reverse Stock Split

May 15, 2015

OncoSec Medical Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market

May 14, 2015

Vista Partners Publishes May 2015 Macroeconomic & Investment Newsletter

May 13, 2015

Robert H. Pierce, MD, Chief Scientific Officer of OncoSec Medical, Invited to Present at 11th Annual PEGS Conference in Boston

May 7, 2015

Vista Partners Updates Coverage on OncoSec Medical (Ticker: ONCS); Price Target $1.20

May 6, 2015

OncoSec Medical to Present at Prominent Scientific and Investment Conferences in May

May 4, 2015

Vista Partners Publishes April 2015 Macroeconomic & Investment Newsletter

April 8, 2015

OncoSec Medical to Present at Needham & Company’s 14th Annual Healthcare Conference

April 2, 2015

OncoSec Medical CEO Punit Dhillon to Host Live Webinar to Provide Corporate Update and 2015 Outlook

March 17, 2015

OncoSec Medical Announces Six Months Results for Fiscal Year End 2015

March 12, 2015

OncoSec Medical to Present at Prominent Scientific and Investment Conferences in March

March 4, 2015

Heat Biologics, Inc. and OncoSec Medical Inc. Announce Collaboration to Evaluate Combination of Immunotherapy Platforms

February 18, 2015

OncoSec Medical Inc. and Heat Biologics, Inc. Announce Collaboration to Evaluate Combination of Immunotherapy Platforms

February 18, 2015

OncoSec Medical to Present at Two Events in February

February 3, 2015

Vista Partners Initiates Coverage on OncoSec Medical (Ticker: ONCS); Price Target $1.20

January 13, 2015

OncoSec Medical Obtains Allowance of Key Patent Application for Intratumoral Delivery of Plasmid IL-15

January 13, 2015

OncoSec Medical Plans to Initiate Pilot Study in Triple Negative Breast Cancer

January 12, 2015

OncoSec Medical to Present at Three Events in January

January 7, 2015

OTC Markets Group Welcomes Newly Verified OTCQB Companies – Jan. 6

January 6, 2015